A Sign Of Future Biosimilars Litigation?

Law360, New York (December 5, 2011, 1:14 PM EST) -- On Oct. 28, 2011, the U.S. District Court for the District of Massachusetts granted plaintiffs Momenta Pharmaceuticals Inc. and Sandoz Inc.'s motion for preliminary injunction against defendants Amphastar Pharmaceuticals Inc., International Medication Systems Ltd. and Watson Pharmaceuticals Inc. See Momenta Pharmaceuticals Inc., et al. v. Amphastar Pharmaceuticals Inc., et al., No. 1:11-cv-11681-NMG (D. Mass. Oct. 28, 2011) ("Momenta opinion").

The Momenta plaintiffs had previously brought suit for infringement of Momenta's patents concerning quality-control methods for generic versions of Sanofi-Aventis' branded drug Lovenox (enoxaparin). And while the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.